Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome

OBJECTIVE: To determine the safety and efficacy of orally delivered 4-aminopyridine (4-AP) in persons with Guillain-Barré Syndrome (GBS) >6 months from initial diagnosis. DESIGN: A randomized, double-blind, placebo-controlled, crossover study. SETTING: Tertiary care clinical outpatient program. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Meythaler, Jay M., Brunner, Robert C., Peduzzi, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212006/
https://www.ncbi.nlm.nih.gov/pubmed/34179759
http://dx.doi.org/10.1016/j.arrct.2021.100123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212006/
https://www.ncbi.nlm.nih.gov/pubmed/34179759
http://dx.doi.org/10.1016/j.arrct.2021.100123

Ejemplares similares